article
Growth hormone’s influence on neuropsychiatric disorders
The discovery of a mechanism involving anxiolytic effects of GH may lead to the development of new classes of anxiolytic drugs.
List view / Grid view
Post-traumatic stress disorder (PTSD)
article
Discovering the principles of nervous system function
Dr William Schafer, of the MRC Laboratory of Molecular Biology, focuses on the cellular and molecular mechanisms of behaviour, which is one of the fundamental problems of biology. Schafer and his colleagues have studied the nematode Caenorhabditis elegans, using a variety of approaches such as optogenetic neuroimaging and high content…
news
50 year old blood pressure drug offers alternative treatment for PTSD
US scientists offer a new purpose for the blood pressure drug clonidine as a treatment to reduce the affects of PTSD.
news
Stem cell study reveals how neurons from PTSD patients react to stress
The findings provide insight into how genetics can make someone more susceptible to developing PTSD following trauma exposure.
article
Innovative treatments: the new frontier for mental health
In this exclusive piece, Adrien Châtillon, Co-Founder and CEO of Actipulse Neuroscience, explores the future of treatment for diseases that impact mental health.
news
Non-hallucinogenic version of ibogaine could treat addiction and depression
A non-hallucinogenic version of the psychedelic drug ibogaine could treat psychiatric disorders, pre-clinical trials have shown.
news
Potential peptide treatment could prevent onset of PTSD
A study has identified a protein complex elevated in PTSD patients and developed a peptide to disrupt it, preventing the recall of fear memories in early tests and paving the way for new therapies.
news
Scientists identify mechanism that links epigenetic change to memory reconsolidation
Researchers in the U.S. have identified a new link between epigenetic changes in the brains of rats and resulting translational control during fear memory reconsolidation.
news
Harvard researchers develop multiregional brain-on-a-chip
Harvard University researchers have developed a multiregional brain-on-a-chip that models the connectivity between three distinct regions of the brain.
news
PTSD risk in military lowered by wearing sleep optimisation device
17 August 2016 | By Niamh Louise Marriott, Digital Content Producer
Recent studies show that sleep disturbance is not only a negative outcome from PTSD, it may also contribute to its onset...
news
Chronos Therapeutics appoints new VPs for MS and PTSD research
4 August 2016 | By Niamh Marriott, Digital Content Producer
Chronos Therapeutics, a biotech company researching ageing diseases, brain and nervous system disorders, have announced the appointment of Dr Fraser Murray and Dr Timothy Schulz-Utermoehl, as Vice Presidents of Pre-Clinical Development...
news
PTSD linked to low levels of adiponectin
12 May 2016 | By Victoria White, Digital Content Producer
The UT Health Science Centre at San Antonio has filed for patent protection on the finding because it may eventually lead to a drug to treat PTSD...
news
SGK1 identified as potential target to reverse effects of PTSD
28 October 2015 | By Victoria White
Experimentally reducing SGK1 activity in rats induced learned helplessness ( a behaviour thought to mimic one aspect of PTSD), while overexpressing the protein reduced it...
news
Promising new target for cognitive disorders identified
17 August 2015 | By Victoria White
Genetically altered mice could form the basis for research into new treatments for cognitive disorders such as Alzheimer’s disease and schizophrenia...
